184 related articles for article (PubMed ID: 27327283)
1. Comparison of Ranibizumab 0.5 mg Versus 1.0 mg for the Treatment of Patients With Clinically Significant Diabetic Macular Edema: A Randomized, Clinical Trial.
Ferrone PJ; Jonisch J
Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6):536-43. PubMed ID: 27327283
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
3. Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab.
Ashraf M; Souka AA; ElKayal H
Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):230-236. PubMed ID: 28297035
[TBL] [Abstract][Full Text] [Related]
4. Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.
Pieramici DJ; Wang PW; Ding B; Gune S
Ophthalmology; 2016 Jun; 123(6):1345-50. PubMed ID: 26992841
[TBL] [Abstract][Full Text] [Related]
5. Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness.
Shah CP; Heier JS
Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):836-9. PubMed ID: 27631479
[TBL] [Abstract][Full Text] [Related]
6. Monthly Versus Treat-and-Extend Ranibizumab for Diabetic Macular Edema: A Prospective, Randomized Trial.
Eichenbaum DA; Duerr E; Patel HR; Pollack SM
Ophthalmic Surg Lasers Imaging Retina; 2018 Nov; 49(11):e191-e197. PubMed ID: 30457655
[TBL] [Abstract][Full Text] [Related]
7. COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA: Two-Year Randomized Single-Blind Controlled Trial Results.
Lafuente M; Ortín L; Argente M; Guindo JL; López-Bernal MD; López-Román FJ; García MJ; Domingo JC; Lajara J
Retina; 2017 Jul; 37(7):1277-1286. PubMed ID: 27787443
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.
Ebneter A; Waldmeier D; Zysset-Burri DC; Wolf S; Zinkernagel MS
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):549-555. PubMed ID: 27714513
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting.
Hrarat L; Fajnkuchen F; Boubaya M; Lévy V; Sarda V; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A
Ophthalmologica; 2016; 236(4):207-214. PubMed ID: 27898414
[TBL] [Abstract][Full Text] [Related]
11. Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema.
Wong Y; Steel DHW; Habib MS; Stubbing-Moore A; Bajwa D; Avery PJ;
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):733-742. PubMed ID: 27957600
[TBL] [Abstract][Full Text] [Related]
12. Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials.
Boyer DS; Nguyen QD; Brown DM; Basu K; Ehrlich JS;
Ophthalmology; 2015 Dec; 122(12):2504-13.e1. PubMed ID: 26452713
[TBL] [Abstract][Full Text] [Related]
13. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
[TBL] [Abstract][Full Text] [Related]
14. Topical Squalamine 0.2% and Intravitreal Ranibizumab 0.5 mg as Combination Therapy for Macular Edema Due to Branch and Central Retinal Vein Occlusion: An Open-Label, Randomized Study.
Wroblewski JJ; Hu AY
Ophthalmic Surg Lasers Imaging Retina; 2016 Oct; 47(10):914-923. PubMed ID: 27759857
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema.
Minami Y; Nagaoka T; Ishibazawa A; Yoshida A
BMC Ophthalmol; 2017 Mar; 17(1):28. PubMed ID: 28292270
[TBL] [Abstract][Full Text] [Related]
16. Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose).
Do DV; Sepah YJ; Boyer D; Callanan D; Gallemore R; Bennett M; Marcus DM; Halperin L; Sadiq MA; Rajagopalan N; Campochiaro PA; Nguyen QD;
Eye (Lond); 2015 Dec; 29(12):1538-44. PubMed ID: 26228291
[TBL] [Abstract][Full Text] [Related]
17. Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.
Murakami T; Suzuma K; Uji A; Yoshitake S; Dodo Y; Fujimoto M; Yoshitake T; Miwa Y; Yoshimura N
Jpn J Ophthalmol; 2018 May; 62(3):292-301. PubMed ID: 29460019
[TBL] [Abstract][Full Text] [Related]
18. THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA.
Lafuente M; Ortín L; Argente M; Guindo JL; López-Bernal MD; López-Román FJ; Domingo JC; Lajara J
Retina; 2019 Jun; 39(6):1083-1090. PubMed ID: 29474306
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study.
Sepah YJ; Sadiq MA; Boyer D; Callanan D; Gallemore R; Bennett M; Marcus D; Halperin L; Hassan M; Campochiaro PA; Nguyen QD; Do DV;
Ophthalmology; 2016 Dec; 123(12):2581-2587. PubMed ID: 27707550
[TBL] [Abstract][Full Text] [Related]
20. Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema.
Moshfeghi AA; Shapiro H; Lemmon LA; Gune S
Ophthalmol Retina; 2018 Feb; 2(2):86-90. PubMed ID: 31047350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
